Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals
NCT ID: NCT01363869
Last Updated: 2013-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2011-06-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
NCT01923597
Neural Effects of Green Tea Extract on Dorsolateral Prefrontal Cortex
NCT01615289
Green Tea Effect on Anthropometric, Oxidation and Inflammation Parameters in Physically Active vs. Sedentary Elders
NCT02077660
Effects of Green Tea on Cardiometabolic Outcomes
NCT06795438
Green Tea Consumption and Coronary Heart Disease
NCT00005548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Green tea is one of the most frequently consumed beverages, particularly in Japan. Green tea contains high level of catechins, in which Epigallocatechin gallate (EGCG) is the most abundant compound among other types of catechins. Antioxidant effect contributes to various potential health benefits of green tea. Several in-vitro studies have found that green tea inhibits xanthine oxidase activity and subsequently decreases reactive oxygen species (ROS) and uric acid production. We therefore would like to investigate the hypouricemic effects of green tea.
The study consists of three periods with a total duration of four weeks. The first week is the control period. The following two weeks is the interventional period and the last week is the follow up period. Thirty healthy participants will be randomly assigned into three experimental groups, receiving 2 gm/day, 4 gm/day and 6 gm/day (in capsule, two times after meal) of green tea extract during interventional period. Blood and urine samples will be taken at the beginning and at the end of each study period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Green tea extracts 2 gm/day
Green tea extracts 2 gm/day for 14 days
green tea extracts 2 gm/day
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 2 grams per day.
Green tea extracts 4 gm/day
Green tea extracts 4 gm/day for 14 days
green tea extracts 4 gm/day
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 4 grams per day.
Green tea extracts 6 gm/day
Green tea extracts 6 gm/day for 14 days
green tea extracts 6 gm/day
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 6 grams per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
green tea extracts 2 gm/day
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 2 grams per day.
green tea extracts 4 gm/day
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 4 grams per day.
green tea extracts 6 gm/day
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 6 grams per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy individuals
* Normal renal and liver function from blood tests
Exclusion Criteria
* Currently using any medication or nutritional supplement product that may affect serum uric acid level
* Serum creatinine higher than 1.5 mg/dl
* Abnormal serum Aspartate aminotransferase (AST) and/or Alanine transaminase (ALT)
* Greater than 15% change in serum uric acid during control period
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kanon Jatuworapruk
Kanon Jatuworapruk M.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kanon Jatuworapruk, M.D
Role: PRINCIPAL_INVESTIGATOR
Department of Internal medicine, Faculty of Medicine, Chiang Mai University, Thailand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine, Faculty of Medicine, Chiang Mai University
Chiang Mai, Chiang Mai, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MED-11-02-07-13-X
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.